Tag: Human Papillomavirus (HPV)
HPV Vaccine Coverage in Children Remains Lower Than Prepandemic
However, recovery seen in monthly volume of vaccine doses administered
Many Females Receiving HPV Vaccination After Recommended Age
Vaccination against HPV before sexual debut advised for maximum effectiveness in female individuals
Total Number of HPV Vaccination Encounters Down During Pandemic
However, there was an increase seen in vaccinations per encounter, with seasonal variation
HPV Vaccination, Infection Rates Examined in U.S. Women
Reduction in HPV-16/18 infection prevalence seen among a recent birth cohort of vaccinated and unvaccinated 18- to 26-year-old women
HPV Vaccination May Cut Risk for CIN2+ Recurrence
Effect estimate stronger for CIN2+ for disease related to HPV subtypes HPV 16 or HPV 18
HPV-Related Throat Cancer Outcomes in Men Vary by Race, Ethnicity
Cancer-specific mortality for HPV-related oropharyngeal cancer higher among non-Hispanic Black and Hispanic men than White men
2015 to 2020 Saw Increase in HPV Vaccination Rates Among Teens
Larger increases in coverage seen among boys than girls, with narrowing of coverage gap
Increasing Impact of HPV Vaccination Seen in the United States
Impact on 4vHPV-type prevalence in 2015 to 2018 for 14- to 24-year-old females 90 percent among vaccinated, 74 percent among unvaccinated
HPV-Associated Cancer Incidence Starting to Increase
Cervical cancer incidence plateaued in highest-income counties, increased in lowest-income counties in recent years
Incidence of Oropharyngeal Cancer Projected to Rise in U.S. Men
Under a status quo scenario based on current levels of HPV vaccination, 792,000 OPC cases in men would be prevented by the year 2100
